Reflections on the U.S. - India Standoff on Generics

From Commission on Smart Global Health Policy Wed Nov 5 2014, 20:19:06

The latter were not the only critics he faced while in the United States. He also met with multinational CEOs unhappy with India's commercial regulatory environment, including those of pharmaceutical giants Merck and Hospira that have longstanding complaints about India's application of its patent laws. Modi's business-friendly election platform has created hopes that he will reverse what multinationals perceive to be an unfair competitive environment in India. For U.S. and European pharmaceutical companies, India's emergence as the leading supplier of low-cost generic drugs has been particularly galling.

[view whole blog post ]
 See More    |     Report Abuse



blogAfrica is allAfrica.com's platform to help you keep an ear on the African blogosphere. We draw diverse voices from around the world who post regularly and insightfully about African issues. Bloggers, submit your blog's rss-feed!